why choose us

First received: February 07, 2023

Clinical Trial: Istradefylline Effect Protocol on Parkinson's Disease Tremor

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Parkinson Disease

Study Type: INTERVENTIONAL


Official Title: Istradefylline Effect on Parkinson's Disease Tremor, Motor Symptoms and Non-motor Symptoms

Brief Summary: This is an investigator-initiated trial.In this 6-month open label, single arm, exploratory pilot study, the investigator intends to enroll a pilot sample of 25 patients with Parkinson's disease who are being started on the novel FDA approved medication "Istradefylline'' as an add on therapy for management of their motor symptoms (based on the judgment of the movement disorders specialist, if patients are in sub-optimal management of their symptoms on maximum tolerable dose of their…

Read more